Standard BioTools Inc.
LAB
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpā¦ read more
Healthcare
Diagnostics & Research
15 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.68
Price-0.82%
$0.00
1Y
Price
Market Cap
$265.764m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-62.5%
EBITDA Margin-213.8%
Net Profit Margin-223.0%
Free Cash Flow Margin-62.5%
EBITDA Margin-213.8%
Net Profit Margin-223.0%
Free Cash Flow MarginRevenue
$86.255m
+1.1%
1y CAGR+4.7%
3y CAGR+5.7%
5y CAGREarnings
-$94.084m
-25.6%
1y CAGR-21.9%
3y CAGR-1.2%
5y CAGREPS
-$0.25
-25.0%
1y CAGR+27.1%
3y CAGR+35.6%
5y CAGRBook Value
$561.123m
$639.114m
Assets$77.991m
Liabilities$29.491m
DebtDebt to Assets
4.6%
-0.4x
Debt to EBITDAFree Cash Flow
-$94.483m
-14.3%
1y CAGR-66.0%
3y CAGR-36.9%
5y CAGRNo items found.
Press Releases
Statements and updates from the company